| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10732 | 2021 |
| Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report … L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ... Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010 | 386 | 2010 |
| Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance L Bonapace, BC Bornhauser, M Schmitz, G Cario, U Ziegler, FK Niggli, ... The Journal of clinical investigation 120 (4), 1310-1323, 2010 | 383 | 2010 |
| Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice) I Knuesel, M Mastrocola, RA Zuellig, B Bornhauser, MC Schaub, ... European Journal of Neuroscience 11 (12), 4457-4462, 1999 | 254 | 1999 |
| IKZF1plus Defines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia M Stanulla, E Dagdan, M Zaliova, A Möricke, C Palmi, G Cazzaniga, ... Journal of Clinical Oncology 36 (12), 1240-1249, 2018 | 248 | 2018 |
| Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options U Fischer, M Forster, A Rinaldi, T Risch, S Sungalee, HJ Warnatz, ... Nature genetics 47 (9), 1020-1029, 2015 | 240 | 2015 |
| Ex vivo drug response profiling detects recurrent sensitivity patterns in drug-resistant acute lymphoblastic leukemia V Frismantas, MP Dobay, A Rinaldi, J Tchinda, SH Dunn, J Kunz, ... Blood, The Journal of the American Society of Hematology 129 (11), e26-e37, 2017 | 215 | 2017 |
| Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or-7 S McComb, PK Chan, A Guinot, H Hartmannsdottir, S Jenni, MP Dobay, ... Science advances 5 (7), eaau9433, 2019 | 208 | 2019 |
| The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse OR Bandapalli, S Schuessele, JB Kunz, T Rausch, AM Stütz, N Tal, ... haematologica 99 (10), e188, 2014 | 135 | 2014 |
| CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres D Walter, S Satheesha, P Albrecht, BC Bornhauser, V D'Alessandro, ... PloS one 6 (5), e19506, 2011 | 131 | 2011 |
| Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL S McComb, J Aguadé-Gorgorió, L Harder, B Marovca, G Cario, C Eckert, ... Science translational medicine 8 (339), 339ra70-339ra70, 2016 | 107 | 2016 |
| Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models C Thiollier, CK Lopez, B Gerby, C Ignacimouttou, S Poglio, Y Duffourd, ... Journal of Experimental Medicine 209 (11), 2017-2031, 2012 | 107 | 2012 |
| Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment M Schmitz, P Breithaupt, N Scheidegger, G Cario, L Bonapace, ... Blood, The Journal of the American Society of Hematology 118 (7), 1854-1864, 2011 | 96 | 2011 |
| Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia C Dafflon, VJ Craig, H Mereau, J Gräsel, B Schacher Engstler, G Hoffman, ... Leukemia 31 (6), 1269-1277, 2017 | 95 | 2017 |
| Leukemia surfaceome analysis reveals new disease-associated features P Mirkowska, A Hofmann, L Sedek, L Slamova, E Mejstrikova, ... Blood, The Journal of the American Society of Hematology 121 (25), e149-e159, 2013 | 84 | 2013 |
| USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T-cell leukemia Q Jin, CA Martinez, KM Arcipowski, Y Zhu, BT Gutierrez-Diaz, KK Wang, ... Clinical Cancer Research 25 (1), 222-239, 2019 | 82 | 2019 |
| Cell and Molecular Determinants of In Vivo Efficacy of the BH3 Mimetic ABT-263 against Pediatric Acute Lymphoblastic Leukemia Xenografts S Suryani, H Carol, TN Chonghaile, V Frismantas, C Sarmah, L High, ... Clinical cancer research 20 (17), 4520-4531, 2014 | 80 | 2014 |
| Pharmacological disruption of the Notch transcription factor complex R Lehal, J Zaric, M Vigolo, C Urech, V Frismantas, N Zangger, L Cao, ... Proceedings of the National Academy of Sciences 117 (28), 16292-16301, 2020 | 76 | 2020 |
| Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway BC Bornhauser, L Bonapace, D Lindholm, R Martinez, G Cario, ... Blood, The Journal of the American Society of Hematology 110 (6), 2084-2091, 2007 | 72 | 2007 |
| MSAP is a novel MIR-interacting protein that enhances neurite outgrowth and increases myosin regulatory light chain BC Bornhauser, PA Olsson, D Lindholm Journal of Biological Chemistry 278 (37), 35412-35420, 2003 | 72 | 2003 |
Martin StanullaHannover Medical SchoolBestätigte E-Mail-Adresse bei mh-hannover.de
